Syneos Health, Inc. - (SYNH): Price and Financial Metrics


Syneos Health, Inc. - (SYNH)

Today's Latest Price: $51.58 USD

0.29 (0.57%)

Updated Sep 25 4:00pm

Add SYNH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

SYNH Stock Summary

  • With a one year PEG ratio of 166.16, Syneos Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 82.15% of US stocks.
  • Syneos Health Inc's stock had its IPO on November 7, 2014, making it an older stock than merely 21.2% of US equities in our set.
  • The volatility of Syneos Health Inc's share price is greater than that of merely 19.52% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Syneos Health Inc, a group of peers worth examining would be FWONA, CLGX, NUE, SND, and WEX.
  • SYNH's SEC filings can be seen here. And to visit Syneos Health Inc's official web site, go to www.syneoshealth.com.
SYNH Daily Price Range
SYNH 52-Week Price Range

SYNH Stock Price Chart Technical Analysis Charts


SYNH Price/Volume Stats

Current price $51.58 52-week high $74.25
Prev. close $51.29 52-week low $30.02
Day low $50.58 Volume 2,545,674
Day high $51.79 Avg. volume 715,216
50-day MA $60.27 Dividend yield N/A
200-day MA $57.35 Market Cap 5.39B

Syneos Health, Inc. - (SYNH) Company Bio


Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.


SYNH Latest News Stream


Event/Time News Detail
Loading, please wait...

SYNH Latest Social Stream


Loading social stream, please wait...

View Full SYNH Social Stream

Latest SYNH News From Around the Web

Below are the latest news stories about Syneos Health Inc that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Hedge Funds Have Never Been This Bullish On Syneos Health, Inc. (SYNH)

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […]

Yahoo | September 16, 2020

Syneos Health Announces Pricing of Secondary Offering of Common Stock

MORRISVILLE, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 7,000,000 shares of the Company’s common stock (the “Offering”) at a price to the public of $59.75 per share. Syneos Health is not selling and will not receive any proceeds from the proposed sale of the shares by the selling stockholders in this Offering. The Offering is expected to close on September 17, 2020, subject...

Yahoo | September 16, 2020

Thomas H. Lee and Advent offload Syneos health shares

Syneos Health (SYNH) has commenced an underwritten secondary offering by Thomas H. Lee Partners and Advent of 7M common sharesSyneos Health is not selling any shares and will not receive any proceeds.The Company has agreed to repurchase from the underwriters ~$30M common shares....

Seeking Alpha | September 15, 2020

Syneos Health Announces Secondary Offering of Common Stock

MORRISVILLE, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of 7,000,000 shares of the Company’s common stock (the “Offering”) pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). Syneos Health is not selling any shares and will not receive any proceeds from the sale of the shares by the selling stockholders in the Offering. The Company has agreed to repurchas...

Yahoo | September 15, 2020

Syneos Health (SYNH) Down 8.2% Since Last Earnings Report: Can It Rebound?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 5, 2020

Read More 'SYNH' Stories Here

SYNH Price Returns

1-mo -14.69%
3-mo -7.89%
6-mo 23.99%
1-year -4.46%
3-year -0.14%
5-year 23.46%
YTD -13.27%
2019 51.14%
2018 -9.75%
2017 -17.11%
2016 8.43%
2015 88.83%

Continue Researching SYNH

Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:

Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7773 seconds.